Filing Details

Accession Number:
0001213900-24-013645
Form Type:
13G Filing
Publication Date:
2024-02-13 19:00:00
Filed By:
Sands Arthur T
Company:
Nurix Therapeutics Inc. (NASDAQ:NRIX)
Filing Date:
2024-02-14
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Arthur T. Sands 2,707,896 0 2,707,896 0 2,707,896 5.4%
Filing
 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934

(Amendment No. )*

 

Nurix Therapeutics, Inc.

(Name of Issuer)

 

Common Stock, par value $0.001 per share

(Title of Class of Securities)

 

67080M103

(CUSIP Number)

 

December 31, 2023

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

  Rule 13d-1(b)
  Rule 13d-1(c)
  Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

  

 

 

 

CUSIP No. 67080M103

13G

 

Page 2 of 5 Pages

 

1

NAMES OF REPORTING PERSONS/I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

Arthur T. Sands

 

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

 

 

(a) ☐

(b) ☐

3

SEC USE ONLY

 

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

United States

 

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

5

SOLE VOTING POWER

2,707,896(1)

 

6

SHARED VOTING POWER

0

 

7

SOLE DISPOSITIVE POWER

2,707,896(1)

 

8

SHARED DISPOSITIVE POWER

0

 

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

2,707,896(1)

 

10

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 

 

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

5.4%(2)

 

12

TYPE OF REPORTING PERSON

IN

 

 

(1)Includes (i) 308,333 shares of Common Stock, (ii) 1,799,563 shares underlying options to purchase Common Stock that are exercisable within 60 days of December 31, 2023, and (iii) 150,000 shares of Common Stock held by each of CMS Family Trust DTD, EES Family Trust DTD, IGS Family Trust DTD and LAS Family Trust DTD. Dr. Sands is the trustee of the CMS Family Trust, EES Family Trust, IGS Family Trust and LAS Family Trust.
  
(2)Based on 48,718,552 shares of the Issuer’s Common Stock outstanding as of December 31, 2023.

 

 

 

 

CUSIP No. 67080M103

13G

 

Page 3 of 5 Pages

  

Item 1(a) Name of Issuer:
   
  Nurix Therapeutics, Inc.
   
Item 1(b) Address of Issuer’s Principal Executive Offices:
   
  1700 Owens Street, Suite 205
  San Francisco, California 94158
   
Item 2(a) Name of Person Filing:
   
  Arthur T. Sands
   
Item 2(b) Address of Principal Business Office or, If None, Residence
   
  c/o Nurix Therapeutics, Inc.
  1700 Owens Street, Suite 205
  San Francisco, California 94158
   
Item 2(c) Citizenship:
   
  United States
   
Item 2(d) Title of Class of Securities:
   
  Common Stock, $0.001 par value per share
   
Item 2(e) CUSIP Number:
   
  67080M103
   
Item 3. Not applicable.

 

Item 4. Ownership
     
  (a) Amount Beneficially Owned:  
     
    2,707,896 (1)
     
  (b) Percent of Class:
     
    5.4%(2)
     
  (c)   Number of shares as to which the person has:
     
  (i) Sole power to vote or direct the vote:  
       
      2,707,896(1)
       
  (ii) Shared power to vote or direct the vote:
       
      0
       
  (iii) Sole power to dispose or to direct the disposition of:
       
      2,707,896 (1)
       
  (iv) Shared power to dispose or to direct the disposition of:
       
      0

 

(1) Includes (i) 308,333 shares of common stock, (ii) 1,799,563 shares underlying options to purchase Common Stock that are exercisable within 60 days of December 31, 2023, and (iii) 150,000 shares of Common Stock held by each of CMS Family Trust DTD, EES Family Trust DTD, IGS Family Trust DTD and LAS Family Trust DTD. Dr. Sands is the trustee of the CMS Family Trust, EES Family Trust, IGS Family Trust and LAS Family Trust.
   
(2) Based on 48,718,552 shares of the Issuer’s Common Stock outstanding as of December 31, 2023.

 

 

 

CUSIP No. 67080M1039

13G

 

Page 4 of 5 Pages

 

Item 5. Ownership of Five Percent or Less of a Class
   
  Not applicable.
   
Item 6. Ownership of More Than Five Percent on Behalf of Another Person
   
  Not applicable.
   
Item 7. Identification and Classification of Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person
   
  Not applicable.
   
Item 8. Identification and Classification of Members of the Group
   
  Not applicable.
   
Item 9. Notice of Dissolution of Group
   
  Not applicable.
   
Item 10. Certifications
   
  Not applicable.

 

 

 

 

CUSIP No. 67080M1039

13G

 

Page 5 of 5 Pages

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: February 14, 2024  
 
  By: /s/ Arthur T. Sands
  Name: Arthur T. Sands